Posted inMarket Contineum Therapeutics CEO Stengone Sells $41,141 in Company Stock Contineum Therapeutics CEO Marino J. Stengone recently sold over $41,000 in company shares. Discover the transaction details and market impact. Posted by Prasenjit Bhowmik November 16, 2026